ThinkSabio

$RGNX

$8.11▲ +5.1% YTD

8 SEC 13D/G filings tracked · Last updated Nov 5, 2026

Filing History
News
RGNX ▲ +5.1% - REGENXBIO Inc.
CP $8.11▲ +5.1%Nov 5, 2026 · ThinkSabio Blog

$RGNX RGNX - REGENXBIO Reports Third Quarter 2026 Financial Results and Operational Highlights…

News
RGNX ▲ +2.0% - REGENXBIO Inc.
CP $7.30▲ +2.0%Nov 3, 2026 · ThinkSabio Blog

$RGNX RGNX - REGENXBIO to Participate in Stifel 2026 Healthcare Conference…

News
RGNX ▼ -0.4% - REGENXBIO Inc.
CP $7.25▲ -0.4%Oct 29, 2026 · ThinkSabio Blog

$RGNX RGNX - REGENXBIO to Host Conference Call on November 5 to Discuss Third Quarter 2026 Financial Results and Operational Highlights…

SEC 13D/G
RGNX - REGENXBIO Inc. - SEC Filing Update (13-OCT-2026) | ThinkSabio - Stocks Simplified
$7.13▼ -47.50%Oct 13, 2026 · ThinkSabio Blog

$RGNX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #RGNX REGENXBIO Inc. : $7.13 Sector: Healthcare | YTD: 🔽 -47.50%…

News
RGNX ▲ +3.5% - REGENXBIO Inc.
CP $8.35▲ +3.5%Oct 12, 2026 · ThinkSabio Blog

$RGNX RGNX - REGENXBIO to Host Investor Event Highlighting Surabgene Lomparvovec (Sura-vec) in Wet AMD on October 20…

News
RGNX ▲ +0.5% - REGENXBIO Inc.
CP $7.48▲ +0.5%Oct 5, 2026 · ThinkSabio Blog

$RGNX int Outperform @ Mizuho pt 22…

News
RGNX ▼ -2.5% - REGENXBIO Inc.
CP $7.32▲ -2.5%Sep 24, 2026 · ThinkSabio Blog

$RGNX RGNX - REGENXBIO Presents Positive Three-Year Durability Data for Surabgene Lomparvovec in Diabetic Retinopathy at Retina Society Annual Scienti…

News
RGNX ▼ -0.2% - REGENXBIO Inc.
CP $8.92▲ -0.2%Sep 8, 2026 · ThinkSabio Blog

$RGNX RGNX - REGENXBIO to Participate in Upcoming Investor Conferences…